Achema middle east

News

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, announced it...

Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell Therapy

Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that they are entering into an agreement for the development of...

Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil

Bharat  Biotech announced  that  it  has  signed  an agreement  with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil. A team from Precisa Medicamentos has visited...

US FDA grants emergency use authorization to Quanterixs Simoa SARS-CoV-2 N protein antigen test

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced that the Food and Drug Administration (FDA) has issued an...

Softbox appoints new Technical Solutions Specialist to further extend technical support to customers

Softbox, a leading global innovator and provider of passive temperature controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, has announced...

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI in the I-SPY COVID-19 Trial

NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical...

UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile

The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response. The effort to establish...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »